Increased chemerin serum levels in hyperandrogenic and normoandrogenic women from Argentina with polycystic ovary syndrome

References

• Apridonidze T, Essah PA, Iuorno MJ, et al. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(4):1929–1935.
   PubMed Web of Science ®Google Scholar
• Cussons AJ, Watts GF, Burke V, et al. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Hum. Reprod. 2008;23(10):2352–2358.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 2004;81:19–25.
   Web of Science ®Google Scholar
• Escobedo J, Schargrodsky H, Champagne B, et al. Prevalence of the Metabolic Syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol. 2009;8:52.
   PubMed Web of Science ®Google Scholar
• Bozaoglu K, Bolton K, McMillan J, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology. 2007;148(10):4687–4694.
   PubMed Web of Science ®Google Scholar
• Roman AA, Parlee SD, Sinal CJ. Chemerin: a potential endocrine link between obesity and type 2 diabetes. Endocrine. 2012;42(2):243–251.
   PubMed Web of Science ®Google Scholar
• Wang Q, Kim JY, Xue K, et al. Chemerin, a novel regulator of follicular steroidogenesis and its potential involvement in polycystic ovarian syndrome. Endocrinology. 2012;153(11):5600–5611.
   PubMed Web of Science ®Google Scholar
• Abruzzese GA, Cerrrone GE, Gamez JM, et al. Lipid accumulation product (LAP) and Visceral Adiposity Index (VAI) as markers of insulin resistance and metabolic associated disturbances in young argentine women with polycystic ovary syndrome. Horm Metab Res. 2017;49(1):23–29.
   PubMed Web of Science ®Google Scholar
• Pasternak RC. Report of the Adult Treatment Panel III: the 2001 National Cholesterol Education Program guidelines on the detection, evaluation and treatment of elevated cholesterol in adults. Cardiol Clin. 2003;21(3):393–398.
   PubMedGoogle Scholar
• Nora GM, Litvak L, María Marta A, et al. Homa index in healthy subjects.Determinación del índice homa en sujetos presuntamente sanos. Estudio epidemiológico multicéntrico (resultados preliminares). RAEM. 2005;42:12–19.
   Google Scholar
• Millán J, Pintó X, Muñoz A, et al. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757–765.
   PubMedGoogle Scholar
• McLaughlin T, Reaven G, Abbasi F, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96(3):399–404.
   PubMed Web of Science ®Google Scholar
• Amato MC, Giordano C, Galia M, for the AlkaMeSy Study Group, et al. Visceral Adiposity Index. Diabetes Care. 2010;33(4):920–922.
   PubMed Web of Science ®Google Scholar
• Huang R, Yue J, Sun Y, et al. Increased serum chemerin concentrations in patients with polycystic ovary syndrome: relationship between insulin resistance and ovarian volume. Clin Chim Acta. 2015;450:366–369.
   PubMed Web of Science ®Google Scholar
• Tan BK, Chen J, Farhatullah S, et al. Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes. 2009;58(9):1971–1977.
   PubMed Web of Science ®Google Scholar
• Di Renzo JA, Casanoves F, Balzarini MG, et al. Infostat Version 2011 [Internet]. 2011. Available from: www.infostat.com.ar.
   Google Scholar
• Salazar MR, Carbajal HA, Espeche WG, et al. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. Am J Cardiol. 2012;109(12):1749–1753.
   PubMed Web of Science ®Google Scholar
• Avena S, Via M, Ziv E, et al. Heterogeneity in genetic admixture across different regions of Argentina. PLOS One. 2012;7(4):e34695.
   PubMed Web of Science ®Google Scholar
• Reverchon M, Ramé C, Bertoldo M, et al. Adipokines and the female reproductive tract [Internet]. Int J Endocrinol. 2014;2014:1–10.
   Web of Science ®Google Scholar
• Reverchon M, Cornuau M, Ramé C, et al. Chemerin inhibits IGF-1-induced progesterone and estradiol secretion in human granulosa cells. Hum Reprod. 2012;27(6):1790–1800.
   PubMed Web of Science ®Google Scholar
• Lima PDA, Nivet A-L, Wang Q, et al. Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages. Biol Reprod. 2018;99(4):838–852.
   PubMed Web of Science ®Google Scholar
• Guzel EC, Celik C, Abali R, et al. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome. Gynecol Endocrinol. 2014;30(6):419–422.
   PubMed Web of Science ®Google Scholar
• Ademoglu E, Berberoglu Z, Carlioglu A, et al. Higher levels of circulating chemerin in both lean and obese patients with polycystic ovary syndrome. Minerva Ginecol. 2014;66:535–542.
   PubMedGoogle Scholar
• Guvenc Y, Var A, Goker A, et al. Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome. J Int Med Res. 2016;44(4):796–805.
   PubMed Web of Science ®Google Scholar
• Yang S, Wang Q, Huang W, et al. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women? Gynecol Endocrinol. 2016;32(1):38–41.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhong Y, Ding Y, et al. Elevated serum chemerin in Chinese women with hyperandrogenic PCOS. Gynecol Endocrinol. 2014;30(10):746–750.
   PubMed Web of Science ®Google Scholar
• Kort DH, Kostolias A, Sullivan C, et al. Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol. 2015;31(2):152–155.
   PubMed Web of Science ®Google Scholar
• Foda AA, Foda EA, El-Negeri MA, et al. Serum chemerin levels in polycystic ovary syndrome after metformin therapy. Diabetes Metab Syndr. 2019;13(2):1309–1315.
   PubMed Web of Science ®Google Scholar
• Yang X, Quan X, Lan Y, et al. Serum chemerin level in women with PCOS and its relation with the risk of spontaneous abortion. Gynecol Endocrinol. 2018;34(10):864–867.
   PubMed Web of Science ®Google Scholar